Xponance, Inc. Staar Surgical CO Transaction History

Xponance, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 13, 2023	SELL	$50.45 - $72.82 $19,978 - $28,836	-396 Reduced 5.28%	7,099 $373,000
Q1 2023 Apr 17, 2023	BUY	$51.25 - $79.34 $461 - $714	9 Added 0.12%	7,495 $479,000
Q4 2022 Jan 23, 2023	SELL	$46.82 - $76.2 $93 - $152	-2 Reduced 0.03%	7,486 $0
Q3 2022 Oct 24, 2022	SELL	$70.55 - $111.58 $9,453 - $14,951	-134 Reduced 1.76%	7,488 $528,000
Q2 2022 Aug 02, 2022	BUY	$50.24 - $80.48 $22,256 - $35,652	443 Added 6.17%	7,622 $541,000
Q1 2022 Apr 20, 2022	SELL	$57.98 - $93.5 $8,001 - $12,903	-138 Reduced 1.89%	7,179 $573,000
Q4 2021 Jan 31, 2022	SELL	$88.02 - $127.79 $7,481 - $10,862	-85 Reduced 1.15%	7,317 $668,000
Q3 2021 Nov 05, 2021	SELL	$122.75 - $162.68 $31,915 - $42,296	-260 Reduced 3.39%	7,402 $952,000
Q2 2021 Aug 12, 2021	BUY	$105.76 - $154.96 $240,075 - $351,759	2,270 Added 42.1%	7,662 $1.17 Million
Q1 2021 May 10, 2021	BUY	$78.5 - $126.48 $423,272 - $681,980	5,392 New	5,392 $568,000

251

47.3M

427K

206K

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.11B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

Stay updated on Xponance, Inc. with notifications on news.